Central Trust Company’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2
Closed -$378 1677
2026
Q1
$378 Hold
2
﹤0.01% 1516
2025
Q4
$398 Buy
+2
New +$404 ﹤0.01% 1467
2022
Q3
Sell
-5
Closed 1417
2022
Q2
$0 Hold
5
﹤0.01% 1456
2022
Q1
$0 Buy
+5
New +$411 ﹤0.01% 1483
2017
Q3
Sell
-50
Closed 1356
2017
Q2
$0 Buy
+50
New +$872 ﹤0.01% 1305

Other funds holding THC

Central Trust Company's THC Position: Q2 2026 in Review

Central Trust Company sold out of Tenet Healthcare (THC) in Q2 2026, closing a stake of 2 shares — an estimated $378 sold.

Central Trust Company first reported a position in THC in Q2 2017 and held it in 5 quarters. The position peaked at $398 in Q4 2025. 679 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Central Trust Company reported no remaining Tenet Healthcare position as of Q2 2026 after selling out during the quarter.
  • Central Trust Company sold 2 Tenet Healthcare shares in Q2 2026, an estimated $378.
  • Central Trust Company first reported a position in Tenet Healthcare in Q2 2017 and held it in 5 quarters.
  • Central Trust Company's Tenet Healthcare position peaked at $398 in Q4 2025.
  • 679 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Central Trust Company's 13F filing for Q2 2026, filed 31 Jul 2026.